DApagliflozin Cardiovascular Effects on Patients at End-stage REnal Disease

Clinical trial NCT05685394 · UNKNOWN

Trial details

NCT number: NCT05685394
Sponsor: University of Campinas, Brazil
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

End-stage Kidney Disease

Start date: 2023-01-24
Primary completion: 2024-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.